tbuckley/cabot-search huggingface dataset:
OA07.04 Effectiveness of NELSON versus PLCOm2012 Lung Cancer Screening Eligibility Criteria: First Results from the German HANSE Study
Authors: J. Vogel-Claussen, B.A. Bollmann, K. May, S. Stiebeler, S. Dettmer, A. Faron, A. Kuhlmann, G. Schmid-Bindert, R. Kaaks, J. Barkhausen, S. Bohnet, M. Reck
Journal: Journal of Thoracic Oncology (2023)
EP13.03-12 Prophylactic Cranial and Consolidation Thoracic Radiation in Extensive Stage Small Cell (ES-SCLC) Lung Cancer in the Chemo-immunotherapy Era
Authors: A.J. Gross, S. Margevicius, P. Fu, D.S. Bruno, A. Dowlati, T. Biswas
Journal: Journal of Thoracic Oncology (2023)
OA01.03 Benmelstobart with Anlotinib plus Chemotherapy as First-line Therapy for ES-SCLC: A Randomized, Double-blind, Phase III Trial
Authors: Y. Cheng, R. Yang, J. Chen, W. Zhang, C. Xie, Q. Hu, N. Zhou, C. Huang, S. Wei, H. Sun, X. Li, Y. Yu, J. Lai, H. Yang, H. Fang, H. Chen, P. Zhang, K. Gu, Q. Wang, J. Shi, T. Yi, X. Xu, X. Ye, D. Wang, C. Xie, C. Liu, Y. Zheng, D. Lin, W. Zhuang, P. Lu, G. Yu, J. Li, Y. Gu, B. Li, R. Wu, O. Jiang, Z. Wang, G. Wu, H. Lin, D. Zhong, Y. Xu, Y. Shu, D. Wu, X. Chen, J. Wang, M. Wang
Journal: Journal of Thoracic Oncology (2023)
OA22.06 Changes in Cognition after Osimertinib, with or without SRS, in EGFRm NSCLC with Brain Metastases: a Pooled Analysis of RCTs
Authors: Y.Y. Soon, S. Lefresne, K. Robledo, A. Nichol, M. Pinkham, A. Sahgal, C.K. Lee, A. Parmar, Y. Huang, M. Doherty, B. Solomon, D. Shultz, I.W.K. Tham, A. Sacher, J.C.S. Tey, C.N. Leong, W.Y. Koh, Y. Ang, J. Low, C. Yong, M.C. Lim, A.P. Tan, R. Soo, C. Ho, F. Hegi-Johnson
Journal: Journal of Thoracic Oncology (2023)
OA22.03 The Addition of Multisite SBRT to Ipilimumab and Nivolumab in First Line Metastatic NSCLC: The COSINR Trial
Authors: A. Juloori, C.M. Bestvina, K.B. Pointer, S.P. Pitroda, M.E. Abazeed, R.R. Katipally, A.P. Sivananthan, P.C. Hoffman, T. Mohammed, S. Rayani, M. Rampurwala, S. Narula, M.C. Garassino, R.R. Weichselbaum, E.E. Vokes, J.D. Patel, S.J. Chmura
Journal: Journal of Thoracic Oncology (2023)
EP14.01-06 Multimodal Treatment in Malignant Pleural Mesothelioma: An Institutional Experience of 432 Patients over a 29 Year Period
Authors: B. Mosleh, T. Klikovits, K. Sinn, C. Lang, D. Gompelmann, K. Hoetzenecker, M.A. Hoda
Journal: Journal of Thoracic Oncology (2023)
MA17.11 Spatial Transformation in Mesothelioma Involves a Hypoxia-TGF Beta-EMT axis that is Reversible via PRX3 Inhibition
Authors: M. Zhang, T. Messier, A. Nakas, P. Wells-Jordan, C. Poile, D. Seward, J. Dzialo, V. Gibson, A. Bzura, G. Naumov, B. Cunniff, D.A. Fennell
Journal: Journal of Thoracic Oncology (2023)
EP13.06-01 Anlotinib Promotes the Phagocytosis and M1 Polarization of Macrophages through Inhibiting CD47 via NF-κB Pathway in SCLC
Authors: X. Xia, X. Wu, G. Chen, M. Chen, X. Wang, W. Wang, W. Pi, D. Lv, H. Yang
Journal: Journal of Thoracic Oncology (2023)
OA20.04 Clinical Significance of IASLC Proposed Pathologic Criteria for Invasion in Resected Non-mucinous Lung Adenocarcinoma
Authors: T.H. Hong, S. Hwang, Y.-L. Choi, J.H. Han, G. Lee, Y.J. Jeon, J. Lee, S.Y. Park, J.H. Cho, Y.S. Choi, J. Kim, Y.M. Shim, J. Cho, H.K. Kim
Journal: Journal of Thoracic Oncology (2023)
Letter to the Editor: Recognizing the new nomenclature requires a comprehensive analysis of the prevalence, severity, and long-term outlook for SLD and subclassifications
Authors: Haoxuan Zou, Yan Xie
Journal: Hepatology (2023)

Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, Sichuan 610041, China Correspondence Yan Xie, Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, Sichuan 610041, China. Email: [email protected]
Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial
Authors: Simone Redaelli, Dario von Wedel, Maxime Fosset, Aiman Suleiman, Guanqing Chen, Julie Alingrin, Michelle N. Gong, Ognjen Gajic, Valerie Goodspeed, Daniel Talmor, Maximilian S. Schaefer, Boris Jung
Journal: Intensive Care Medicine (2023)
EP17.01-05 Lung Cancer (Internet-Based) Delphi (LuCiD): a Delphi Consensus to Develop Australasian Thoracic Oncology Quality Indicators
Authors: J. Nash, E. Stone, S. Vinod, T. Leong, P. Dawkins, R. Stirling, F. Brims
Journal: Journal of Thoracic Oncology (2023)
EP14.03-09 Expression of Fibroblast Activation Protein in Intrathoracic Solitary Fibrous Tumor
Authors: T. Kimura, T. Hiroshima, T. Watabe, E. Fukui, T. Kanou, N. Ose, S. Funaki, Y. Shintani
Journal: Journal of Thoracic Oncology (2023)
EP12.02-02 Treatment Patterns and Economic Burden of Brain Metastases (BM) in Patients with ALK+ mNSCLC Receiving ALK TKIs
Authors: H. Le, D. Benjumea, B. Li, A. Shao, A. Rava, M. Silver, S. Vaghela, D. Thomaidou, J. Lin
Journal: Journal of Thoracic Oncology (2023)
P2.10-13 Characteristics and Outcomes of Hispanic Patients with RET-Fusion Positive NSCLC Treated in Real-World Practice
Authors: O. Arrieta, A. Cardona, V.C. Cordeiro de Lima, E. Figueiredo Saldanha, L. Corrales, H. Freitas, L. Gil-Santana, C. Martin, D. Enrico, R. Motta, L. Rojas, J. Zuluaga, L. Viola, S. Martínez, G. Cruz, A. Valencia, L. Raez, C. Rolfo
Journal: Journal of Thoracic Oncology (2023)
EP13.07-09 The Role of Radiotherapy in Extensive-Stage Small Cell Lung Cancer after Durvalumab-Based Immunochemotherapy: A Retrospective Study
Authors: X. Dong, F. Tong, L. Chen, Y. Kong, R. Zhang, P. Ding, S. Zhang, Y. Wang, R. Zhou, X. Pu, B. Chen, F. Liang, Q. Tan, Y. Xu, L. Wu
Journal: Journal of Thoracic Oncology (2023)
OA06.04 Surgery after Neoadjuvant Immuno-Chemoradiotherapy in (Borderline) Resectable NSCLC: Results from the INCREASE Trial
Authors: C. Dickhoff, D. Heineman, F. Schneiders, I. Houda, J. Veltman, S. Hashemi, M. Fransen, T. Radonic, I. Bartelink, L. Meijboom, D. Oprea-Lager, N. Bouwhuis, T. de Gruijl, S. Senan, I. Bahce
Journal: Journal of Thoracic Oncology (2023)
MA19.03 Sex Differences in the Prediction of Future Lung Cancer Risk Based on a Single Low-Dose Chest Computed Tomography Scan
Authors: J. Simon, P. Mikhael, I. Tahir, A. Graur, A. Fata, J.-A. Shepard, F. Jacobson, R. Barzilay, L. Sequist, L. Pace, F.J. Fintelmann
Journal: Journal of Thoracic Oncology (2023)
EP06.05-07 Non Small Cell Lung Cancer Associated to Dipnech: A Clinico-Pathological Analysis of 32 Cases
Authors: M.T. Congedo, A.G. Napolitano, D. Nachira, M. Chiappetta, E. Meacci, L. Petracca Ciavarella, M.L. Vita, V. Porziella, L. Calandriello, A. Cancellieri, G. Rindi, S. Margaritora, F. Lococo
Journal: Journal of Thoracic Oncology (2023)
OA09.03 STK11/LKB1 Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy in NSCLC: Results From Three Randomized Trials
Authors: A. Li, Y. Wang, Z. Yu, L. He, S. Fu, W. Du, L. Luo, Y. Zhou, W. Fang, Y. Yang, L. Zhang, S. Hong
Journal: Journal of Thoracic Oncology (2023)
OA01.04 Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results
Authors: S.V. Liu, R. Dziadziuszko, S. Sugawara, S. Kao, M. Hochmair, F. Huemer, G. Castro, L. Havel, R.B. Caro, G. Losonczy, J.-S. Lee, D. Kowalski, Z. Andric, R. Califano, A. Veatch, G. Gerstner, M. Batus, S. Morris, M. Kaul, M. Siddiqui, H. Li, W. Zhang, B. Nabet, M. Reck
Journal: Journal of Thoracic Oncology (2023)
MA03.06 Respiratory Tract Malignancy-associated Mortality Attributable to Particulate Matter in South Asia from the Global Burden of Disease
Authors: G.S.J. Barreto-D'Silva, T.N. Lobo, C. Isckarus, S. Al-Kindi, K.J. D'Silva, K.S. Gunturu
Journal: Journal of Thoracic Oncology (2023)
MA17.09 BAP1 Deficiency Inflames the TME &amp; is a Candidate Biomarker for Improved Immunotherapy in Malignant Pleural Mesothelioma
Authors: D. Xu, Y. Gao, H. Yang, T.M. Marti, T. Losmanova, P. Dorn, Y. Shu, R. Peng
Journal: Journal of Thoracic Oncology (2023)
EP12.02-06 Comparative Efficacy and Safety of Lorlatinib vs Alectinib and Brigatinib Using Matching Adjusted Indirect Comparisons (MAIC)
Authors: C.A. Garcia, D. Abrahami, A. Polli, C. Chandler, M. Tan, J.M. Kelton, D. Thomaidou, T. Bauer
Journal: Journal of Thoracic Oncology (2023)
MA15.07 NC318, an Anti-Siglec-15 Humanized mAb, Alone and in Combination with Pembrolizumab in Immunotherapy Pretreated NSCLC
Authors: S. Gettinger, S. Goldberg, A. Chiang, F. Wilson, S.Y.Y. Kim, E. Rowen, H. Gerrish, E. Duffield, M. Davies, V. Dest, R. Jackson, None J. Pope, H. Myint, S. Langermann, W. Cheng, D. Rimm, L. Chen, R. Herbst
Journal: Journal of Thoracic Oncology (2023)
OA21.04 Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study
Authors: N. Leighl, B.C. Cho, S. Hiret, J.-Y. Han, K.H. Lee, C. Llacer Perez, M.G. Krebs, F. De Braud, E. Haura, R.E. Sanborn, J.C.-H. Yang, C.A. Shu, K. Goto, M. Nishio, J. Zhao, Z. Wang, P. Tomasini, E. Felip, J.W. Goldman, S.-H.I. Ou, M. Boyer, G. Gao, S. Qu, J.C. Curtin, X. Lyu, A. Roshak, R.W. Schnepp, P. Kim, J. Mertz, M. Thayu, S.M. Shreeve, R.E. Knoblauch, A.I. Spira
Journal: Journal of Thoracic Oncology (2023)
EP12.01-48 A Study of Aumolertinib Monotherapy or Combination Treated EGFR-mutated NSCLC Patients with Symptomatic Brain Metastases
Authors: X. Zhang, M. Zhang, X. Du, G. Zhang, Y. Niu, C. Wei, L. Guo, C. Shi, H. Wang
Journal: Journal of Thoracic Oncology (2023)
MA13.05 Concurrent Aumolertinib Plus Icotinib for First-Line Treatment of EGFR-Mutant NSCLC with CNS Metastases: A Prospective Phase I/II Study
Authors: M.J. Huang, M. Yu, Y.L. Gong, Y.Y. Li, Y.M. Liu, F. Peng, Y. Yu, W.G. Xiu, Y.S. Wang, B.W. Zou, H. Fan, L.Q. Zhong, T.Q. Liu, X.F. Wang, Y. Xu, L. Zhou, Y. Lu
Journal: Journal of Thoracic Oncology (2023)
EP06.04-01 Challenge to Detect CTC-derived EGFR Mutation of Non-small Cell Lung Carcinoma by Unique Blood-Filtration Device
Authors: S. Morita, H. Dejima, H. Nakanishi, R. Takeyama, S. Kohmaru, T. Watanabe, S. Shirai, Y. Yamauchi, Y. Saito, Y. Sakao
Journal: Journal of Thoracic Oncology (2023)
OA14.04 Three-Year Outcomes with First-Line Pembrolizumab, in Patients with Non-Small-Cell Lung Cancer and A PD-L1 Tumor Proportion Score &gt;90%
Authors: B. Ricciuti, A. Arielle Elkrief, J. Lin, M. Altan, J. Alessi, M. Gandhi, F. Pecci, G. Lamberti, A. Di Federico, X. Wang, C. Pabon, J. Zhang, J. Lindsey, B. Sharma, K. Felt, M. Nishino, L. Sholl, S. Rodig, J. Gainor, J. Heymach, A. Schoenfeld, M. Awad
Journal: Journal of Thoracic Oncology (2023)
MA18.05 Biomarkers for Brain Metastases Risk and Survival Benefit of Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer
Authors: L. Li, D. Zhang, S. Wang, J. Pang, S. Tang, X. Qin, S. Shi, Q. Ou, Y. Shao, J. Yu, S. Yuan
Journal: Journal of Thoracic Oncology (2023)
WS02.18 Cerebrospinal Fluid ctDNA Based Therapy Associated with Survival of CNS Metastases in Advanced NSCLC: A Large Scale, Comprehensive Study
Authors: M.-M. Zheng, L.-B. Tang, H.-Y. Tu, B.-Y. Jiang, K. Yin, J.-J. Yang, X.-C. Zhang, Y. Pan, B.-C. Wang, H.-J. Chen, H. Sun, Z. Wang, C.-R. Xu, W.-Z. Zhong, T. Hou, D.-Q. Zhu, Q. Zhou, Y.-S. Li, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2023)
EP06.03-06 Clinical Impact of EGFR vs KRAS Mutations in Multifocal Lung Adenocarcinoma
Authors: J. Jiang, M.F. Berry, N.S. Lui, D.Z. Liou, W.L. Trope, L.M. Backhus, J.B. Shrager
Journal: Journal of Thoracic Oncology (2023)
WS02.12 Aumolertinib Plus Anlotinib as 1st-Line Treatment for EGFR Mutant Non-Small Cell Lung Cancer: A Phase II Trial (ALWAYS)
Authors: H.l. Chen, T.t. Xia, G.b. Huang, H.y. Ye, Y.p. Luo, H.g. Chen, M.l. Liu, S.j. Li, Z.x. Yang
Journal: Journal of Thoracic Oncology (2023)
EP12.01-62 Osteoblastic Bone Reaction in Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Treated with Osimertinib
Authors: K. Kanaoka, H. Sumikawa, A. Tamiya, Y. Inagaki, Y. Taniguchi, K. Nakao, Y. Matsuda, K. Okishio
Journal: Journal of Thoracic Oncology (2023)
Re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor–defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.05.023
Authors: Ziwei Wang, Shuxiong Zeng, Chuanliang Xu
Journal: European Urology (2023)
EP14.02-07 Atypical Response to Metronomic Chemotherapy in a Patient with Advanced Thymoma
Authors: J. Baena, A. Terron, M. Herrera-Juarez, J. Torres-Jiménez, H. Bote, U. Perez-Gonzalez, L. Paz-Ares, J. Zugazagoitia
Journal: Journal of Thoracic Oncology (2023)
OA21.05 Tepotinib + Osimertinib in EGFR-mutant NSCLC with MET Amplification Following 1L Osimertinib: INSIGHT 2 Primary Analysis
Authors: T.M. Kim, V. Guarneri, V.P. Jye, L.B. Khaw, J.-J. Yang, M. Wislez, C. Huang, L. Chong Kin, J. Mazieres, L.M. Tho, H. Hayashi, N. Nhung, P.L. Chia, F. De Marinis, J. Raskin, Q. Zhou, G. Finochhiaro, X. Le, D. Tan, S. Brutlach, A. O'Brate, S. Adrian, K. Berghoff, B. Ellers-Lenz, N. Karachaliou, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2023)
OA12.05 Surgical Outcomes with Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC (AEGEAN)
Authors: T. Mitsudomi, J.V. Heymach, M. Reck, J.M. Taube, S. Gao, Y. Horio, J. You, G. Li, D. Van Luong, S. Saeteng, F. Tanaka, G. Kulesza, S.B. Watzka, L. Urban, Z. Szalai, H. Akamatsu, J.-H. Kang, F.J. Orlandi, G.Z. Mukhametshina, A. Pircher, C.H.A. Teixeira, M. Aperghis, G.J. Doherty, R. Doake, T.M. Fouad, D. Harpole
Journal: Journal of Thoracic Oncology (2023)
EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer
Authors: W.L. Tan, S.H. Tan, D.S.W. Tan, G.G.Y. Lai, M.-K. Ang, A. Jain, R. Kanesvaran, T. Rajasekaran, S.P.L. Saw, Y.L. Teh, J. Chan, Q.S. Ng, D.W.-T. Lim
Journal: Journal of Thoracic Oncology (2023)
Author Correction: MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages
Authors: Jingjing Cao, Lili Ji, Yanxia Zhan, Xia Shao, Pengcheng Xu, Boting Wu, Pu Chen, Luya Cheng, Xibing Zhuang, Yang Ou, Fanli Hua, Lihua Sun, Feng Li, Hao Chen, Zhaocai Zhou, Yunfeng Cheng
Journal: Cellular and Molecular Immunology (2023)
MA16.10 An Update 5 Years of Randomized Phase 2 Study (PRoT-BM Trial)
Authors: O. Arrieta, F. Maldonado, J.G. Turcott, H.B. Bravo, L.A.B. Cabrera-Miranda, A.B. Regino, A.F. Cardona, J.G. de la Garza
Journal: Journal of Thoracic Oncology (2023)
EP13.01-03 Does Oligometastases state exist in patients of Small Cell Lung Cancer? - A Small Retrospective Analysis from a Tertiary Cancer Centre
Authors: R. Nabariya, A. Tibdewal, J.P. Agarwal, N. Mummudi, A. Agrawal, K. Prabhash, V. Noronha, A. Singh, N. Menon
Journal: Journal of Thoracic Oncology (2023)
EP14.01-07 Patients Who Undergo Surgery Survive Longer than Those Who Refuse Surgery
Authors: A. Nakamura, A. Fukuda, K. Takegahara, T. Nakamichi, A. Kutoda, M. Hashimoto, S. Matsumoto, N. Kondo, S. Hasegawa
Journal: Journal of Thoracic Oncology (2023)
MA03.10 The Interim Analysis of Can-Prevent-Lung Trial: Canakinumab for The Prevention of Lung Cancer
Authors: J. Zhang, M. Salehjahromi, M. Godoy, M. Antonoff, E. Ostrin, X. Le, C. Gay, M.V. Negrao, L. Byers, C. Lu, G.B. Blumenschein, D. Rice, G.L. Walsh, R. Rajaram, B. Sepesi, S.H. Lin, W. Hofstetter, R. Mehran, A. Vaporciyan, S. Moghaddam, J.J. Lee, J. Wu, J.V. Heymach
Journal: Journal of Thoracic Oncology (2023)
EP06.03-17 The Prognostic Impact of Postoperative EGFR Mutation Status in Lung Cancer Patients with Stage II - III
Authors: S. Nakamura, T. Hase, Y. Takada, H. Iwashimizu, Y. Imamura, S. Okado, Y. Nomata, H. Watanabe, O. Noritake, K. Nakanishi, Y. Kadomatsu, H. Ueno, T. Kato, T. Mizuno, M. Ishii, T.F. Chen-Yoshikawa
Journal: Journal of Thoracic Oncology (2023)
Tuberculosis prevention: current strategies and future directions
Authors: Anca Vasiliu, Leonardo Martinez, Rishi K. Gupta, Yohhei Hamada, Tara Ness, Alexander Kay, Maryline Bonnet, Martina Sester, Stefan H.E. Kaufmann, Christoph Lange, Anna M. Mandalakas
Journal: Clinical Microbiology and Infection (2023)
MA14.03 Targetable Driver Alterations in Non-adenocarcinoma NSCLC: Population-Based Prevalence Data from the National Swedish Lung Cancer Registry
Authors: J. Isaksson, A. Berglund, L. Willén, P. Xanthoulis, A. Edsjö, F. Enlund, M. Planck, A. Vikström, M. Johansson, A. Hallqvist, G. Wagenius, J. Botling
Journal: Journal of Thoracic Oncology (2023)
EP14.03-08 Pulmonary Metastastasis of Dermatofibrosarcoma Protuberans of the Scalp : A Challenging Mesenchymal Tumor
Authors: A.F. Aulia, S.M. Munir, B. Bergant, A. Makmur, E.S. Tripriadi
Journal: Journal of Thoracic Oncology (2023)
MA11.03 First in Human Prospective Validation of Intraoperative Artificial Intelligence Guided Diagnosis of Indeterminate Lung Nodules
Authors: F. Azari, G. Kennedy, P. Bou-Samra, A. Din, K. Zhang, A. Chang, A. Ibrahimli, A. Galandarova, J. Kucharczuk, S. Singhal
Journal: Journal of Thoracic Oncology (2023)
OA14.05 5-Year Survival of Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With PD-L1 Tumor Proportion Score &lt;1%
Authors: S. Gadgeel, D. Rodríguez-Abreu, B. Halmos, M.C. Garassino, T. Kurata, Y. Cheng, E. Jensen, M. Shamoun, K. Rajagopalan, L. Paz-Ares
Journal: Journal of Thoracic Oncology (2023)
MA18.09 Carboplatin, Etoposide, Bevacizumab, and Atezolizumab in Patients with Extensive-Stage SCLC - GOIRC-01-2019 CeLEBrATE Trial
Authors: G. Lamberti, K. Rihawi, F. Riccardi, F. Mazzoni, A. Follador, A. Bonetti, D. Giardina, C. Genova, F. Bertolini, A. Frassoldati, M. Brighenti, I. Colantonio, G. Pasello, C. Ficorella, S. Cinieri, M. Tiseo, S. Fancelli, E. Andrini, G. Targato, M. Tognetto, L. Boni, A. Ardizzoni
Journal: Journal of Thoracic Oncology (2023)
EP14.01-05 Neo-Adjuvant Immunotherapy in Malignant Pleural Mesothelioma: Report on Three Cases Treated in a Single Institution
Authors: P. Novellis, F. Rossetti, R. Di Fonzo, P. Muriana, C. Lazzari, F.R. Ogliari, A. Bulotta, R. Ferrara, V. Gregorc, G. Veronesi
Journal: Journal of Thoracic Oncology (2023)
EP12.01-58 Continuous CR for EGFR-Mutated NSCLC with Brain Metastasis and Giant Lung Lesion Using Aumolertinib Plus Radiotherapy as First-Line Treatment
Authors: Q. Wu, W. Li, J.T. Wang, D. Pu, None Y. Li, F. Xu
Journal: Journal of Thoracic Oncology (2023)
OA17.04 Long-Term Outcomes by Radiation Technique for Locally-Advanced Non-small Lung Cancer: A Secondary Analysis of NRG Oncology-RTOG 0617 at 5-years
Authors: S.G. Chun, C. Hu, H. Choy, R.U. Komaki, R.D. Timmerman, S.E. Schild, J.A. Bogart, M.C. Dobelbower, W. Bosch, V.S. Kavadi, S. Narayan, P. Iyengar, C.G. Robinson, J. Rothman, A. Raben, M.E. Augspurger, R.M. McRae, R. Paulus, J.D. Bradley
Journal: Journal of Thoracic Oncology (2023)
EP15.03-04 Unscheduled Hospitalizations in Patients with Lung Cancer as a Frailty Event
Authors: J. Peña-López, L. Gutiérrez-Sainz, D. Jiménez-Bou, I. Ruíz-Gutiérrez, C. Navas-Jiménez, J.I. Alonso-Eiros, Á. García-Zamarriego, D. Sánchez-Cabrero, L. Ruíz-Giménez, A. Pertejo, A. Alonso-Babarro, P. Cruz-Castellanos, O. Higuera, J. de Castro
Journal: Journal of Thoracic Oncology (2023)
OA09.06 IMpower151: Phase III Study of Atezolizumab + Bevacizumab + Chemotherapy in 1L Metastatic Nonsquamous NSCLC
Authors: C. Zhou, X. Dong, G. Chen, Z. Wang, X. Wu, Y. Yao, Y. Zhang, Y. Cheng, H. Pan, X. Zhang, J. Cui, L. Wang, X. Chen, X. Li, Z. Wang, Q. Wang, J. He, M. Wang, I. Yan, L. Qian, A. An, A. Cai, Q. Wu, M. Ballinger, L. Wang
Journal: Journal of Thoracic Oncology (2023)
EP13.05-02 Temozolomide-associated Hypermutation and Response to Immunotherapy in Advanced Pulmonary Neuroendocrine Tumors
Authors: W. Buikhuisen, S. Badrising, J. Derks, L. Moonen, S. Burgers, K. Monkhorst, L. Kodach
Journal: Journal of Thoracic Oncology (2023)
EP12.01-24 High-Dose Aumolertinib Combined Intrathecal Chemotherapy for LM from EGFR-Mutated NSCLC with Meningeal Symptoms as the First Symptom
Authors: W. Wang, S.B. Fan, X.P. Huang, M.X. Zhong, J. Guo
Journal: Journal of Thoracic Oncology (2023)
EP12.03-07 A Case Report of Sustained Survival of NSCLC Treated with Combination of Cell Therapy and Immunotherapy
Authors: M.S. DE Guzman, F. Heralde, M.T. Barzaga, A. Bilbao, N. Tan-Liu, M.P. Apelado, J. Panuelos
Journal: Journal of Thoracic Oncology (2023)
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
Authors: Izabela Lepiarz-Raba, Ismail Gbadamosi, Roberta Florea, Rosa Chiara Paolicelli, Ali Jawaid
Journal: Translational Neurodegeneration (2023)

Abstract Microglia, the resident immune cells of the brain, are increasingly implicated in the regulation of brain health and disease. Microglia perform multiple functions in the central nervous system, including surveillance, phagocytosis and release of a variety of soluble factors. Importantly, a majority of their functions are closely related to changes in their metabolism. This natural inter-dependency between core microglial properties and metabolism offers a unique opportunity to modulate microglial activities via nutritional or metabolic interventions. In this review, we examine the existing scientific literature to synthesize the hypothesis that microglial phagocytosis of amyloid beta (Aβ) aggregates in Alzheimer’s disease (AD) can be selectively enhanced via metabolic interventions. We first review the basics of microglial metabolism and the effects of common metabolites, such as glucose, lipids, ketone bodies, glutamine, pyruvate and lactate, on microglial inflammatory and phagocytic properties. Next, we examine the evidence for dysregulation of microglial metabolism in AD. This is followed by a review of in vivo studies on metabolic manipulation of microglial functions to ascertain their therapeutic potential in AD. Finally, we discuss the effects of metabolic factors on microglial phagocytosis of healthy synapses, a pathological process that also contributes to the progression of AD. We conclude by enlisting the current challenges that need to be addressed before strategies to harness microglial phagocytosis to clear pathological protein deposits in AD and other neurodegenerative disorders can be widely adopted.
OA11.03 Prognostic Impact of Ground Glass Opacity Component and Consolidation Size after Sublobar Resection: A Quantitative Analysis
Authors: J.Y. Kim, J.K. Yun, Y. Ahn, M.Y. Kim, G.D. Lee, S. Choi, Y.-H. Kim, D.K. Kim, S.-I. Park, H.R. Kim
Journal: Journal of Thoracic Oncology (2023)
OA03.06 Repotrectinib in Patients with ROS1 Fusion-positive (ROS1+) NSCLC: Update from the Pivotal Phase 1/2 TRIDENT-1 Trial
Authors: B.C. Cho, D.R. Camidge, J.J. Lin, S.-W. Kim, B. Solomon, R. Dziadziuszko, B. Besse, K. Goto, A.J. de Langen, J. Wolf, K.H. Lee, S. Popat, C. Springfeld, M. Nagasaka, E. Felip, N. Yang, S. Lu, S. Kao, V. Velcheti, P. Cheema, S. Stopatschinskaja, M. Mehta, D. Trone, F. Ades, C.Y. Calvet, A. Drilon
Journal: Journal of Thoracic Oncology (2023)
EP14.01-04 Risk Factors Influencing Postoperative Pleural Empyema in Patients with Pleural Mesothelioma after Multimodal Therapy
Authors: P. Henschke, L. Guglielmetti, S. Hillinger, G.-M. Monsch, D. Schneiter, I. Schmitt-Opitz, O. Lauk
Journal: Journal of Thoracic Oncology (2023)
EP06.03-16 Demographic and Genomic Characteristics of Non-Small Cell Lung Cancer Patients with ARID1A Alterations
Authors: E. Al-Obeidi, A. Williams, N. Burkert, K. Pepin, J.K. Hicks, J.E. Gray, S. Stewart, C. Weipert, S. Waqar, D. Spigel, R. Salgia, E. Massarelli, C.S. Baik, J.W. Neal, K. Ramchandran, B. Xia, E.L. Carpenter, C. Aggarwal, J.W. Riess, D. Gandara
Journal: Journal of Thoracic Oncology (2023)
EP12.01-71 Aumolertinib Combination Therapy for EGFR-Mutant NSCLC Patients with Refractory Leptomeningeal Metastasis Following Osimertinib Failure
Authors: H. Ding, T. Xu, X. Wang, W. Cheng, S. Fang
Journal: Journal of Thoracic Oncology (2023)
MA18.11 A Phase Ib/II Study of Senaparib in Combination with Low-dose Temozolomide: Updated Results in Relapsed ES-SCLC Patients
Authors: M.H. Hong, B. Gao, Y. Cheng, B.-Y. Shim, M. Johnson, C.-Y. Liu, S.-W. Kim, K.H. Lee, R. Zielinski, R. Eek, S. Hu, C.-C. Lin, W.-P. Chung, C.-Y. Hsieh, S.X. Cai, Y.E. Tian, L. Liu, T. Niu, C. Halcro, B. Li, M. Zhang, C. Zhang, H. Li, L. Xu, H.T. Hung
Journal: Journal of Thoracic Oncology (2023)